IntegraFin Holdings plc (LON:IHP – Get Free Report) insider Euan Marshall acquired 41 shares of the stock in a transaction that occurred on Monday, September 21st. The stock was purchased at an average price of GBX 371 per share, for a total transaction of £152.11.
Euan Marshall also recently made the following trade(s):
- On Friday, August 21st, Euan Marshall bought 38 shares of IntegraFin stock. The shares were purchased at an average cost of GBX 387 per share, with a total value of £147.06.
- On Wednesday, July 22nd, Euan Marshall bought 39 shares of IntegraFin stock. The stock was purchased at an average price of GBX 390 per share, for a total transaction of £152.10.
- On Tuesday, July 14th, Euan Marshall purchased 84 shares of IntegraFin stock. The stock was purchased at an average cost of GBX 365 per share, for a total transaction of £306.60.
IntegraFin Price Performance
IHP traded down GBX 6.75 on Wednesday, hitting GBX 368.25. 361,675 shares of the company’s stock were exchanged, compared to its average volume of 2,111,489. IntegraFin Holdings plc has a fifty-two week low of GBX 293 and a fifty-two week high of GBX 402. The stock has a market cap of £1.22 billion, a price-to-earnings ratio of 19.28, a P/E/G ratio of 3.14 and a beta of 1.28. The firm has a 50-day moving average price of GBX 383.52 and a 200-day moving average price of GBX 353.62. The company has a current ratio of 250.17, a quick ratio of 0.01 and a debt-to-equity ratio of 5.68.
Analyst Ratings Changes
View Our Latest Research Report on IHP
IntegraFin Company Profile
IntegraFin Holdings plc (IntegraFin) is the holding company for all of the entities involved in the provision of the Transact service. Transact is one of the largest independent wrap platforms in the UK. It offers advisory professionals a comprehensive financial planning infrastructure for investing client assets in a tax-efficient way.
Featured Stories
- Five stocks we like better than IntegraFin
- Quantum and Rare Earths? Implications of the Pasqal/USAR Partnership
- Lockheed’s Stock Hasn’t Priced In Its Own Backlog—Boeing’s Might Already Have
- Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?
- Old Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom
Receive News & Ratings for IntegraFin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntegraFin and related companies with MarketBeat.com's FREE daily email newsletter.
